Significance of Apoptosis Induced by Tumor Necrosis Factor-α and/or Interferon-γ Against Human Gastric Cancer Cell Lines and the Role of the p53 Gene

Surgery Today

Volumn 33, Issue 11, 2003, Pages 847-853

  Fukui, Takami ^a   Matsui, Kouji ^a   Kato, Hiroki ^a   Takao, Hiroshi ^a   Sugiyama, Yasuyuki ^a   Kunieda, Katsuyuki ^a   Saji, Shigetoyo ^a  

^a GIFU UNIVERSITY   (Japan)

Author keywords

Apoptosis; Human gastric cancer cell line; Insulin like growth factor binding protein 3; Interferon ; p53 gene; Tumor necrosis factor

Indexed keywords

DYE; GAMMA INTERFERON; INTERLEUKIN 1BETA CONVERTING ENZYME; PROTEIN P53; SOMATOMEDIN BINDING PROTEIN 3; TUMOR NECROSIS FACTOR ALPHA;

APOPTOSIS; ARTICLE; CANCER CELL CULTURE; COMBINATION CHEMOTHERAPY; CONTROLLED STUDY; DNA MICROARRAY; DOSE RESPONSE; GENE EXPRESSION; GENE MUTATION; HUMAN; HUMAN CELL; IMMUNOTHERAPY; SIGNAL TRANSDUCTION; STAINING; STOMACH CANCER; TARGET CELL; TUMOR SUPPRESSOR GENE; WESTERN BLOTTING;

APOPTOSIS; BIOPSY, NEEDLE; BLOTTING, WESTERN; DNA, COMPLEMENTARY; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, P53; HUMANS; INTERFERON TYPE II; MALE; REFERENCE VALUES; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY; STOMACH NEOPLASMS; TUMOR CELLS, CULTURED; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0242288478     PISSN: 09411291     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00595-003-2620-5     Document Type: Article

References (36)

1. Schulze-Osthoff K, Ferrari D, Los M, Wesselborg S, Peter ME. Apoptosis signaling by death receptors. Eur J Biochem 1998;254:439-59.
2. Saji S, Sugiyama Y, Kunieda K. Pre-and/or post-operative immunochemotherapy for advanced digestive cancer (in Japanese). Gan To Kagaku Ryoho (Jpn J Cancer Chemother) 1997;24:239-49.
3. Yoshida S, Ono M, Shono T, Izumi H, Ishibashi T, Suzuki H, et al. Involvement of interleukin-8, vascular endothelial growth factor, and basic fibroblast growth factor in tumor necrosis factor alpha-dependent angiogenesis. Mol Cell Biol 1997;17:4015-23.
4. Bach EA, Aguet M, Schreiber RD. The IFN gamma receptor: a paradigm for cytokine receptor signaling. Annu Rev Immunol 1997;15:563-91.
5. Hsu H, Shu HB, Pan MG, Goeddel DV. TRADD-TRAF2 and TRADD-FADD interactions define two distinct TNF receptor 1 signal transduction pathway. Cell 1996;84:299-308.
6. Boldin MP, Goncharov TM, Goltsev YV, Wallach D. Involvement of MACH, a novel MORT1/FADD-interacting protease, in Fas/APO-1-and TNF receptor-induced cell death. Cell 1996;85:803-15.
7. Stennicke HR, Jurgensmeier JM, Shin H, Deveraux Q, Wolf BB, Yang X, et al. Pro-caspase-3 is a major physiologic target of caspase-8. J Biol Chem 1998;273:27084-90.
8. Gross A, Yin XM, Wang K, Wei MC, Jockel J, Milliman C, et al. Caspase cleaved BID targets mitochondria and is required for cytochrome c release, while BCL-xL prevents this release but not tumor necrosis factor-R1/Fas death. J Biol Chem 1999;274:1156-63.
9. Jiang XH, Wong BC, Lin MC, Zhu GH, Kung HF, Jiang SH, et al. Functional p53 is required for triptolide-induced apoptosis and AP-1 and nuclear factor-kappaB activation in gastric cancer cells. Oncogene 2001;20:8009-18.
10. Fan XM, Wong BC, Wang WP, Zhou XM, Cho CH, Yuen ST, et al. Inhibition of proteasome function induced apoptosis in gastric cancer. Int J Cancer 2001;93:481-8.
11. Ohnishi K, Ota I, Takahashi A, Yane K, Matsumoto H, Ohnishi T. Transfection of mutant p53 gene depresses X-ray-or CDDP-induced apoptosis in a human squamous cell carcinoma of the head and neck. Apoptosis 2002;7:367-72.
12. Manos EJ, Jones DA. Assessment of tumor necrosis factor receptor and fas signaling pathways by transcriptional profilling. Cancer Res 2001;61:433-8.
13. Sasagawa T, Hlaing M, Akaike T. Synergistic induction of apoptosis in murine hepatoma Hepa1-6 cells by IFN-γ and TNF-α. Biochem Biophys Res Commun 2000;272:674-80.
14. Enzinger C, Wirleitner B, Bock G, Baier-Bitterlich G, Fuchs D. Influence of cytokines tumor necrosis factor-alpha and interferon-gamma on signaling cascades associated with apoptosis in rat PC12 cells. Neurosci Lett 2001;316:157-60.
15. Suk K, Kim S, Kim YH, Kim KA, Chang I, Yagita H, et al. IFN-gamma/TNF-alpha synergism as the final effector in autoimmune diabetes: a key role for STAT1/IFN regulatory factor-1 pathway in pancreatic beta cell death. J Immunol 2001;166:4481-9.
16. Matsumura R, Umemiya K, Goto T, Nakazawa T, Ochiai K, Kagami M, et al. Interferon gamma and tumor necrosis factor alpha induce Fas expression and anti-Fas mediated apoptosis in a salivary ductal cell line. Clin Exp Rheumatol 2000;18:311-8.
17. Ruegg C, Yilmaz A, Bieler G, Bamat J, Chaubert P, Lejeune FJ. Evidence for the involvement of endothelial cell integrin α V β3 in the disruption of the tumor vasculature induced by TNF and IFN-γ. Nat Med 1998;4:408-14.
18. Riccioli A, Starace D, D'Alessio A, Starace G, Padula F, De Cesaris P, et al. TNF-alpha and IFN-gamma regulate expression and function of the Fas system in the seminiferous epithelium. J Immunol 2000;165:743-9.
19. Luttmann W, Dauer E, Schmidt S, Marx O, Hossfeld M, Matthys H, Virchow JC Jr. Effects of interferon-gamma and tumour necrosis factor-alpha on CD95/Fas ligand-mediated apoptosis in human blood eosinophils. Scand J Immunol 2000;51:54-9.
20. Chang-Min K, Weon-Seon H, Jhin-Oh L, Tae-Woong K, Young-Whan K, Jae-Kwan S, et al. Enhancement of cytotoxicity of cisplatin in vitro by recombinant human tumor necrosis factor and/or recombinant human interferon-α-β, and -γ. Jpn J Cancer Res 1989;80:904-9.
21. Sveinbjornsson B, Rushfeldt C, Smedsrod OB, Seljelid R. Cytotoxic effect of cytokines on murine colon carcinoma cells involves TNF-mediated apoptosis. Biochem Biophys Res Commun 1997;240:376-81.
22. Tamura T, Ueda S, Yoshida M, Matsuzaki M, Mohri H, Okubo T. IFN-γ induces ice gene expression and enhances cellular susceptibility to apoptosis in the U937 leukemia cell line. Biochem Biophys Res Commun 1996;229:21-6.
23. Koshiji M, Adachi Y, Taketani S, Takeuchi K, Hioki K, Ikehara S. Mechanisms underlying apoptosis induced by combination of 5-fluorouracil and IFN-γ. Biochem Biophys Res Commun 1997;240:376-81.
24. Kagawa S, Fujiwara T, Hizuta A, Yasuda T, Zhang WW, Roth JA, et al. p53 expression overcomes p21WAF1/CIP1-mediated G1 arrest and induces apoptosis in human cancer cells. Oncogene 1997;15:1903-9.
25. Lanni JS, Lowe SW, Licitra EJ, Liu JO, Jacks T. p53-independent apoptosis induced by paclitaxel through an indirect mechanism. Proc Natl Acad Sci USA 1997;94:9679-83.
26. Baker SJ, Reddy EP. Modulation of life and death by the TNF receptor superfamily. Oncogene 1998;17:3261-70.
27. Wiley SR, Schooley K, Smolak PJ, Din WS, Huang CP, Nicholl JK, et al. Identification and characterization of a new member of the TNF family that induces apoptosis. Immunity 1995;3:673-82.
28. Lin Y, Devin A, Rodriguez Y, Liu ZG. Cleavage of the death domain kinase RIP by caspase-8 prompts TNF-induced apoptosis. Genes Dev 1999;13:2514-26.
29. Varfolomeev EE, Schuchmann M, Luria V, Chiannilkulchai N, Beckmann JS, Mett IL, et al. Targeted disruption of the mouse Caspase8 gene ablates cell death induction by the TNF receptors, Fas/Apo1, and DR3 and is lethal prenatally. Immunity 1998;9:267-76.
30. Chin YE, Kitagawa M, Kuida K, Flavell RA, Fu XY. Activation of the STAT signaling pathway can cause expression of caspase 1 and apoptosis. Mol Cell Biol 1997;17:5328-37.
31. Lee KY, Anderson A, Madani K, Rosen GD. Loss of STAT1 expression confers resistance to IFN-induced apoptosis in ME180 cells. FEBS Lett 1999;459:323-6.
32. Yasuoka Y, Naomoto Y, Yamatsuji T, Takaoka M, Kimura M, Uetsuka H, et al. Combination of tumor necrosis factor alpha and interferon alpha induces apoptotic cell death through a c-myc-dependent pathway in p53 mutant H226br non-small-cell lung cancer cell line. Exp Cell Res 2001;271:214-22.
33. Buckbinder L, Talbott R, Velasco-Miguel S, Takenaka I, Faha B, Seizinger BR, et al. Induction of the growth inhibitor IGF-binding protein 3 by p53. Nature 1995;377:646-9.
34. Anwar A, Zahid AA, Scheidegger KJ, Brink M, Delafontaine P. Tumor necrosis factor-alpha regulates insulin-like growth factor-1 and insulin-like growth factor binding protein-3 expression in vascular smooth muscle. Circulation 2002;105:1220-5.
35. Valentinis B, Bhala A, DeAngelis T, Baserga R, Cohen P. The human insulin-like growth factor (IGF) binding protein-3 inhibits the growth of fibroblasts with a targeted disruption of the IGF-I receptor gene. Mol Endocrinol 1995;9:361-7.
36. Oh Y, Muller HL, Lamson G, Rosenfeld RG. Insulin-like growth factor (IGF)-independent action of IGF-binding protein-3 in Hs578T human breast cancer cells. Cell surface binding and growth inhibition. J Biol Chem 1993;268:14964-71.